You Are Leaving Avistone's Website

You have selected a link that will take you to a site maintained by a third party. Avistone provides this link as a service to website visitors. Avistone is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit. Click 'Cancel' to return to Avistone's site or 'Continue' to proceed.

SCIENCE & INNOVATION

SCIENCE & INNOVATION

A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer

Time:2025-06-11

Drugs: PLB1004

 

NCT Number: NCT06046495

 

Source:

https://clinicaltrials.gov/study/NCT06046495?term=NCT06046495&rank=1